However, Mounjaro is not FDA-approved for weight loss, so its use is exclusively for diabetes control with documented A1C lab results showing levels of 6.5 or higher or confirmation from your primary care provider
If you are someone who has dealt with diarrhea from tirzepatide , the experience will feel familiar, though typically less severe
a subset of MASLD), resolution of steatohepatitis and reduction in liver fibrosis were reported in a greater proportion of patients in the semaglutide group compared to the placebo group [37]
But the NHS has slowed its roll-out of these drugs among those who are eligible because they are worried that the cost of the drugs and the large number possible users might mean GLP-1s take up around half the entire national budget for all drugs
Patients and their doctors may not have been able to make a fully informed decision, weighing the benefits of the drug against its potential for causing a life-altering gastrointestinal injury
In a 24-week study, patients were randomized to receive either glimepiride alone or in combination with metformin, or glimepiride and sitagliptin or both agents also in combination with metformin
